What is the most common genetic alteration associated with sporadic osteosarcoma?

Explanation

## Molecular Genetics of Osteosarcoma **Key Point:** **TP53 mutation** is the most frequently altered gene in sporadic osteosarcoma, found in 50–70% of cases. RB1 inactivation is the second most common alteration (found in ~30% of cases). ### Genetic Alterations in Osteosarcoma | Gene | Frequency | Mechanism | Clinical Context | | --- | --- | --- | --- | | **TP53** | 50–70% | Loss of function; p53 inactivation | Most common in sporadic OS | | **RB1** | ~30% | Inactivation; loss of G1/S checkpoint | Hereditary retinoblastoma syndrome | | **PTEN** | <10% | Loss of function | Cowden syndrome (rare) | | **BRCA1/2** | <5% | Germline mutations | Hereditary breast/ovarian cancer (not primary OS driver) | ### TP53 Inactivation in Osteosarcoma 1. **Loss of cell cycle control** — p53 normally arrests cells at G1/S checkpoint; loss allows uncontrolled proliferation. 2. **Impaired apoptosis** — p53 normally triggers apoptosis in damaged cells; inactivation allows survival of mutated cells. 3. **Genomic instability** — p53 loss permits accumulation of secondary mutations. **High-Yield:** TP53 is mutated in **>50% of sporadic osteosarcomas**. This is the single most common genetic alteration. **Mnemonic:** **"TP53 is TOP in OS"** — TP53 is the TOP (most common) altered gene in Osteosarcoma. ### RB1 Inactivation - Found in ~30% of osteosarcomas. - RB1 loss is particularly associated with **hereditary retinoblastoma syndrome** (Li-Fraumeni-like). - RB1 normally controls G1/S transition; loss allows uncontrolled S-phase entry. **Clinical Pearl:** Patients with **hereditary retinoblastoma** (RB1 germline mutation) have a dramatically increased risk of osteosarcoma (>1000-fold). Conversely, TP53 germline mutations (Li-Fraumeni syndrome) also predispose to osteosarcoma. ### Why NOT the Other Options? - **BRCA1 mutation:** Associated with breast and ovarian cancer, not a primary driver of osteosarcoma. - **RB1 inactivation:** Important but less frequent than TP53 in sporadic OS; more relevant in hereditary retinoblastoma. - **PTEN loss:** Rare in osteosarcoma; associated with Cowden syndrome but not a common OS alteration.